Subscribe to RSS - home infusion

home infusion

NHIA denounces new proposed rule


ALEXANDRIA, Va. – A proposed rule published last week fails to address a “deeply flawed policy” that reimburses home infusion services only on days when a nurse is present in the patient’s home, says the National Home Infusion Association.

CMS proposes payment methodology for home infusion drugs


WASHINGTON – CMS has issued a proposed rule that would group home infusion drugs into three payment categories in preparation for the new home infusion benefit that starts in 2021.

Option Care opens center in Atlanta


ATLANTA – Option Care Enterprises has opened a new state-of-the-art Care Management Center in Atlanta.

Soleo fast tracks growth


MCKINNEY, Texas – Soleo Health has ranked sixth in Dallas’ 50 Fastest-Growing Middle Market Companies by the Dallas Business Journal.

Ascension forms post-acute care division


ST. LOUIS – Ascension has formed a new Post-Acute Services Division and named Daniel “Danny” Stricker as its president, according to McKnight’s Senior Living. Stricker is COO of subsidiary Ascension Living.

BioScrip execs will continue at combined company


DENVER – Key members of BioScrip’s leadership team will continue in executive roles with the combined company following the close of its pending merger with Option Care Enterprises.

PE firm merges three companies to form AleraCare


LOS ANGELES – St. Cloud Capital, a private equity firm based here, has announced a growth capital investment in AleraCare Holdings, a provider of home and community based healthcare and pharmacy services.

BioScrip reports revenue growth


DENVER – BioScrip reported revenues of $179 million for the first quarter of 2019, an increase of 6.2% over the first quarter of 2018. Net loss from continuing operations was $10.3 million vs. $13 million.

Q&A: Option Care's John Rademacher


When the ink dries on the planned merger of two of the country’s leading home infusion services providers, it will form an organization that is deeply committed to patient care, says John Rademacher, CEO of the combined company of Option Care and BioScri

Option Care positions itself as ‘partner of choice’


DENVER, Colo., and BANNOCKBURN, Ill. – Option Care CEO John Rademacher says its merger with BioScrip will create a “powerful, independent platform” in the growing $100 million infusion market.